Peptide Regulation Guides
Educational guides to peptide-related FDA compounding rules, UK MHRA medicines law, Australian TGA access pathways, and WADA anti-doping restrictions.
Regulations change and can depend on route, claim, product source, prescriber status, and jurisdiction. Treat these pages as editorial research notes, not legal advice.
🇺🇸 United States
503A vs 503B Compounding Pharmacies: Peptide Access Guide
Understand the difference between 503A and 503B compounding pharmacies for peptide therapy. Requirements, oversight, and how to verify your pharmacy.
FDA Peptide Categories: Category 1 vs Category 2 Explained
Understand FDA's 503A and 503B bulk-substance categories for compounding, including Category 1, Category 2, Category 3, and peptide safety-risk signals.
Peptide Therapy Laws by State: US Regulatory Guide
State-by-state guide to peptide therapy regulations in the US. Which states allow telehealth prescribing, compounding access, and practitioner requirements.
🇬🇧 United Kingdom
MHRA Peptide Regulation: UK Legal Status Guide
Guide to UK peptide regulation under the MHRA. Covers legal status, research chemicals, prescription requirements, and personal importation rules under UK law.
Legal Status of Peptides in the United Kingdom
Complete guide to the legal status of peptides in the UK. MHRA regulations, Human Medicines Regulations 2012, research chemicals, and what you can legally buy.
🇦🇺 Australia
Personal Importation of Peptides into Australia
Guide to Australia's personal importation scheme for peptides. TGA rules, quantity limits, prescription requirements, and what you need to know.
TGA Peptide Regulation: Australia Legal Status Guide
Guide to Australian peptide regulation under the TGA. Covers Schedule 4 classification, Authorised Prescriber scheme, compounding rules, and personal importation.